SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-059159
Filing Date
2024-05-09
Accepted
2024-05-09 09:21:56
Documents
5
Effectiveness Date
2024-05-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2413781d1_s8.htm S-8 77030
2 EXHIBIT 5.1 tm2413781d1_ex5-1.htm EX-5.1 7234
3 EXHIBIT 23.1 tm2413781d1_ex23-1.htm EX-23.1 1756
4 EX-FILING FEES tm2413781d1_ex-filingfees.htm EX-FILING FEES 15967
5 GRAPHIC tm2413781d1_ex5-1img001.jpg GRAPHIC 4533
  Complete submission text file 0001104659-24-059159.txt   109397
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279243 | Film No.: 24928959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)